Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsGaspar J. Kitange, Jann N. Sarkaria, Brett L. Carlson et al.|Neuro-Oncology|2008Cited by 387
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panelJann N. Sarkaria, C. David James, Lin Yang et al.|Molecular Cancer Therapeutics|2007Cited by 203
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cellsLing Cen, Jann N. Sarkaria, Stephanie Fink et al.|Neuro-Oncology|2012Cited by 187
Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma XenograftsGaspar J. Kitange, Jann N. Sarkaria, Ann C. Mladek et al.|Clinical Cancer Research|2012Cited by 151
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft modelGaspar J. Kitange, Jann N. Sarkaria, Brett L. Carlson et al.|Journal of Neuro-Oncology|2008Cited by 97